Evidence map›Paper›PMID 35269208›Full record

ArticleMaterials (Basel, Switzerland)2022

Performance Evaluation of Tunnel-Slag-Improved High Liquid Limit Soil in Subgrade: A Case Study.

Xiaomeng Zheng, Zhushan Shao, Nannan Zhao, Chenglong Li, Kui Wu

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaomeng ZhengSchool of Civil Engineering, Xi'an University of Architecture and Technology, Xi'an 710055, China.
Zhushan ShaoSchool of Civil Engineering, Xi'an University of Architecture and Technology, Xi'an 710055, China.
Nannan ZhaoSchool of Civil Engineering, Xi'an University of Architecture and Technology, Xi'an 710055, China.
Chenglong LiShum Yip East China Real Estate Development Co., Ltd., Nanjing 210011, China.
Kui WuSchool of Science, Xi'an University of Architecture and Technology, Xi'an 710055, China.

Funding

Natural Science Basic Research Program of Shaanxi Program No. 2022JQ-427
6 · The paper itself

Abstract

The application of tunnel-slag-improved high liquid limit soil as filling materials in subgrade is a green environmental technology. This study explored the influence of tunnel slag mixing on the physical and mechanical properties of improved soils, based on the engineering background of Liyu highway, Guangxi Province, China. Firstly, the optimal moisture content, maximum dry density, shear strength parameters, California bearing ratio (CBR) and resilience modulus of plain and tunnel-slag-improved high liquid limit soils were experimentally determined. Results showed that the direct utilization of untreated soil was unacceptable in subgrade practice. A significant enhancement of integrity of high liquid limit soils could be obtained by tunnel slag mixing, and the value of 15% was determined as the optimal tunnel slag content in soils, leading to improved soil performance meeting the specification requirements. Then, numerical simulation on the stability of subgrade slope of tunnel-slag-improved soils at the content of 15% was conducted. It also reported the long-term subgrade settlements. The feasibility of utilization of tunnel slag in improving properties of high liquid limit soils was further validated. Finally, a good application of tunnel-slag-improved high liquid limit soil as subgrade filling materials in Liyu highway was achieved. The findings in this study could provide useful guidance for similar engineering.

Indexed as

engineering applicationfeasibilityhigh liquid limit soilmechanical propertytunnel slag

Identifiers

PMID35269208
PMCPMC8911939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.